BioStem Technologies, Inc.

BioStem Technologies, Inc. develops, manufactures, and sells placental-derived allografts for advanced wound care and regenerative therapies within the United States. The company's product portfolio includes Vendaje, a structural tissue allograft designed as a protective covering for soft tissue wounds, and Vendaje AC, a thicker version of this structural tissue allograft also used as a protective covering for soft tissue wounds. BioStem Technologies also offers Vendaje OPTIC, a structural tissue allograft specifically for use as a protective covering during the repair of ocular surfaces. Additionally, the company provides American Amnion AC and American Amnion, both human connective tissue matrices intended for homologous use. BioStem Technologies, Inc. was incorporated in 2006 and is headquartered in Fort Lauderdale, Florida. The company changed its name from Caribbean International Holdings Inc. to BioStem Technologies, Inc. in August 2014.